Bedell Frazier Investment Counseling, LLC Biomarin Pharmaceutical Inc Transaction History

Bedell Frazier Investment Counseling, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 14, 2019	SELL	$80.14 - $106.07 $2.76 Million - $3.65 Million	-34,430 Closed	0 $0
Q3 2018 Nov 13, 2018	SELL	$93.92 - $105.72 $46,490 - $52,331	-495 Reduced 1.42%	34,430 $3.34 Million
Q2 2018 Aug 09, 2018	SELL	$76.01 - $99.03 $49,786 - $64,864	-655 Reduced 1.84%	34,925 $3.29 Million
Q1 2018 May 10, 2018	BUY	$77.67 - $92.63 $2.76 Million - $3.3 Million	35,580 New	35,580 $2.88 Million

631

184M

1.63M

1.2M

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $12.2B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

Get notified when there are updates to the investment portfolio of Bedell Frazier Investment Counseling, LLC, based on Form 13F filings with the SEC.

Stay updated on Bedell Frazier Investment Counseling, LLC with notifications on news.